Scanner logic
Why this stock appeared
METROPOLIS appeared because the stored NiftyLens scanner found a market-behaviour observation on 2026-07-27. The scanner review is based on multi-year technical price history, recent daily behaviour, participation, liquidity, relative movement, and post-observation tracking fields before public context is attached. This page labels it as a neutral watch observation, meaning it is kept for educational review without presenting the scanner output as a trading instruction.
After the scanner observation, NiftyLens checks public news and corporate-event context to help readers study what else was visible around the same market day. That context is an explanation layer, not a trading instruction.
Public news and event check
Metropolis Healthcare announced stellar Q4 FY26 results on May 13 via NSE/BSE: consolidated PAT +75% YoY to ₹50.9cr, revenue +23% to ₹424cr, EBITDA +60-67% to ₹100-116cr. Robust demand, margin expansion, 5,000+ centres milestone. Board approved ₹1/share dividend (2nd interim). Growth guidance 13-15% through 2027. Primary stock catalyst from official filings.